Navigation Links
Free Access to Literature Data on Chagas' Disease Offered Online: Collaborative Drug Discovery, Inc. provides Neglected Disease researchers with 'archive mine and collaborate' access to small molecule bioactivity SAR data on parasitic disease
Date:10/17/2007

SAN FRANCISCO, Oct. 17 /PRNewswire/ -- Collaborative Drug Discovery, Inc. (CDD, Inc.) has captured extensive literature data from six years of recent publications focused on the fight against Chagas' disease. Now for the first time these data are available to researchers free of charge, via the CDD Database.

Sources include the Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, the Journal of American Chemical Society, Journal of Ethnopharmacology, Proceedings of the National Academy of Sciences (PNAS), International Journal of Antimicrobial Agents, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Molecular and Biochemical Parasitology, Journal of Inorganic Biochemistry, Acta Topical, and Experimental Parasitology.

The data sets captured include 574 compound structures and just over 350 different enzyme, cell, animal, and toxicity based protocols. The data are conveniently organized so scientists can easily mine for hits, sub-structural motifs or keywords and obtain the original literature reference for more detailed analysis.

These data sets will help researchers better prioritize compounds to test experimentally and build superior models to guide experiments.

This project is the first of a series literature data capture projects focused on drug discovery research into neglected infectious diseases. In addition to literature data, community members also provide open access to some of their experimental results either pre- or post-publication. The CDD global community includes leading researchers from four continents.

To submit other datasets, capabilities, expertise, or models which would be valuable to the Chagas' or neglected disease community, please contact us at info@collaborativedrug.com.

A significant subset of all the community data -- and a range of other data sets such as Chagas' data -- is available openly to the public at no cost. For this historical set of data either visit http://www.collaborativedrug.com/registrations/new or e-mail info@collaborativedrug.com to register for the username and password to the open data sets.

About Collaborative Drug Discovery: CDD is the world's first platform for selectively sharing collaborative drug discovery data. Scientists working with the CDD community platform can pool their research in order to more effectively develop new drug candidates for commercial and humanitarian markets. Conceived in 2003, and formally launched in 2004, Collaborative Drug Discovery (CDD) has been serving the collaborative data needs of researchers for years. The CDD global community includes hundreds of scientists from leading research foundations, academia and industry. A subset of the data is available openly to the public at no cost. For more information, please visit http://www.collaborativedrug.com.


'/>"/>
SOURCE Collaborative Drug Discovery, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Controversial deal on public access of the human genome map
2. Health Canada Gave Access To Unapproved Drugs To AIDS/HIV Patients.
3. Health Care Disparities cause of inaccessibility to new technology
4. Scots Do Not Have Access To Proper Dental Care
5. Speedier Access To Advances In Breast Cancer Sought For Patients
6. Children In Scotland Denied Access To Dental Care
7. Patients Have Right To Access Medical Case Papers: Bombay High Court
8. AIDS Deaths On The Rise Due To Low Access To Antiretroviral Treatment
9. Easy Access To Healthcare Services Essential For Better Survival Rates
10. People Affected By HIV Positive Urge For Better Treatment Access
11. Singapore To Offer More Patients Access To Chronic Disease Management Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... The Professional Squash Association, ... enlisted New York City-based sports and entertainment marketing firm Leverage Agency as its ... for the Professional Squash Association (PSA), which includes first-time ever title sponsorship, naming ...
(Date:3/29/2017)... ... ... pollen is the main cause of hay fever in the United States, with an estimated ... from May to July each year; with the worst time for sufferers being June and ... ( http://www.haymax.us ) provide an effective defense against grass pollen; they are proven in independent ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Youth Futures ... great success and feedback from high school and college students who have participated in ... held July 7-23 and YFI is now accepting applications for enrollment. Visit ...
(Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sports Brand ... brace, which retails normally at $29.97; for the remaining days of March, the ... also been reduced to a special price of just $10 (regular retail price $19.97). ...
(Date:3/29/2017)... Louisiana (PRWEB) , ... March 29, 2017 , ... ... in three Hours at a Walgreens store in Mississippi. AngioGenesis Labs, makers of ... Walgreens Stores in two southeastern states. Ingredients in HeartBoost, an over the counter ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
(Date:3/29/2017)...  Maxor National Pharmacy Services, LLC ("Maxor"), a leading ... Leah Bailey as General Counsel.  Bailey will serve ... With more than 13 years of experience ... on health care, Bailey joins the Maxor team coming ... advised the PBM, Specialty, and Mail Order business areas ...
(Date:3/29/2017)... , March 29, 2017 Varian Medical Systems ... report results for the second quarter of fiscal year 2017 ... 2017.  The news release will be followed by a teleconference ... news release and a link to the conference call webcast ... .  To access the teleconference call and replay: ...
Breaking Medicine Technology: